Brief: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
04/11/2024 21:11
Nov 4 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O :
* ARCUTIS BIOTHERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER
NASDAQ
LISTING RULE 5635(C)(4)
Source text: ID:nGNX4jB7Vj
Further company coverage: ARQT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arcutis Biotherapeutics
See all newsBrief: Arcutis Canada Przoryve Cream 0.05% Receives Health Canada Approval For Atopic Dermatitis
Arcutis Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Arcutis Q2 revenue rises on demand for ZORYVE, lifts 2026 sales outlook
Arcutis Biotherapeutics Inc expected to post earnings of 4 cents a share - Earnings Preview
Brief: Arcutis Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4